The Tools4Patient team has moved our offices to a new building located in the same scientific campus in Louvain-La-Neuve, Belgium in early September, 2020. Since our Inception in 2013, Tools4Patient has been steadily building capability to support the commercialization of Placebell©™ and other technologies in development. The rapid expansion of collaborations with innovative biopharma companies has led to 30% growth of our team – particularly in scientific and operational support areas – over the last year.
Our new facility was designed to allow further expansion while promoting Innovation and collaboration under the umbrella of our corporate values. Tools4Patient’s new offices reflect our corporate brand, mission, values and journey throughout the space. With our expansion in staff and space, Tools4Patient is well-positioned to support ongoing and future projects with the highest level of scientific excellence and integrity.
Tools4Patient remains firmly committed to our mission of developing technologies that accelerate drug development and reduce risk in clinical trials. This portfolio aims to address key sources of clinical data variability by providing a more sophisticated, holistic understand of the individual clinical trial patient. Placebell©™, the first in a suite of products based on patient psychological profiling, aims to reduce the impact of the placebo response and thus reduce the risk of inconclusive trials. Our R&D efforts focus on addressing different sources of data variability, including crisis and emotional stress and variability between clinical sites. Learn more about opportunities to collaborate or contact us for additional information.